Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortality

Journal of Critical Care

Volumn 26, Issue 5, 2011, Pages 460-467

  Turkoglu, Melda ^a   Mirza, Emel ^a   Tunçcan, Özlem Güzel ^a   Erdem, Gökmen Umut ^a   Dizbay, Murat ^a   Yaǧci, Münci ^a   Aygencel, Gülbin ^a   Türköz Sucak, Gülsan ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Acinetobacter baumannii; Critically ill; Hematologic malignancy; Outcome; Risk factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CARBAPENEM DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; NETILMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON;

ACINETOBACTER INFECTION; ADULT; AGE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NASOGASTRIC TUBE; NEUTROPENIA; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEPSIS; UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; CRITICAL ILLNESS; FEMALE; HEMATOLOGIC NEOPLASMS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TURKEY;

EID: 80053448027     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.04.007     Document Type: Article

References (30)

1. Hoheisel G., Lange S., Winkler J., et al. Nosocomial pneumonias in haematological malignancies in the medical intensive care unit. Pneumologie 2003, 57:73-77.
2. Getchell-White S.I., Donowitz L.G., Gröschel D.H. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus. Infect Control Hosp Epidemiol 1989, 10:402-407.
3. Hancock R.E. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 1998, 27(Suppl 1):S93-S99.
4. Friedland I., Stinson L., Ikaiddi M., et al. Phenotypic antimicrobial resistance patterns in Pseudomonas aeruginosa and Acinetobacter: results of a Multicenter Intensive Care Unit Surveillance Study, 1995-2000. Diagn Microbiol Infect Dis 2003, 45:245-250.
5. Mera R.M., Miller L.A., Amrine-Madsen H., et al. Acinetobacter baumannii 2002-2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States. Microb Drug Resist 2010, 16:209-215.
6. Albrecht M.C., Griffith M.E., Murray C.K., et al. Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 2006, 203:546-550.
7. Caricato A., Montini L., Bello G., et al. Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Med 2009, 35:1964-1969.
8. Iregui M., Ward S., Sherman G., Fraser V.J., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268.
9. Horan T., Andrus M., Dudeck M. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
10. Yang W., He B., Zhao M.W. The changing patterns and the associated factors of microbial pathogens in ventilator-associated pneumonia in a respiratory intensive care unit from 1995 to 2004. Zhonghua Jie He He Hu Xi Za Zhi 2008, 31:598-602.
11. Wright M.O. Greater Baltimore Chapter of the Association for Professionals in Infection Control and Epidemiology (APIC) Multi-resistant gram-negative organisms in Maryland: a statewide survey of resistant Acinetobacter baumannii. Am J Infect Control 2005, 33:419-421.
12. Dizbay M., Tunçcan O.G., Seze B.E., et al. Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factors. Scand J Infect Dis 2010, 42:741-746.
13. Cisneros J.M., Reyes M.J., Pachón J., et al. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996, 22:1026-1032.
14. Fagon J.Y., Chastre J., Hance A.J., et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993, 94:281-288.
15. Jang T.N., Lee S.H., Huang C.H., et al. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect 2009, 73:143-150.
16. Garnacho J., Sole-Violan J., Sa-Borges M., et al. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 2003, 31:2478-2482.
17. Falagas M.E., Bliziotis I.A., Siempos I.I. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006, 10:R48.
18. Vandijck D.M., Benoit D.D., Depuydt P.O., et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008, 34:847-855.
19. Chen C.Y., Tsay W., Tang J.L., et al. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 2010, 138:1044-1051.
20. Offidani M., Corvatta L., Malerba L., et al. Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center. Leuk Lymphoma 2004, 45:1617-1621.
21. Puig N., De La Rubia J., Jarque I., et al. Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation. Leuk Lymphoma 2007, 48:2367-2374.
22. Nseir S., Di Pompeo C., Diarra M., et al. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria a case-control study. Crit Care Med 2007, 35:1318-1323.
23. Lu Q., Huang L.S., Zhang R., et al. Following-up of nosocomial lower respiratory infection in patients with hematological malignancies after chemotherapy. Zhonghua Yu Fang Yi Xue Za Zhi 2008, 42:123-126.
24. Baran G., Erbay A., Bodur H., et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 2008, 12:16-21.
25. Jung J.Y., Park M.S., Kim S.E., et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis 2010, 10:228.
26. Erbay H., Yalcin A.N., Serin S., et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 2003, 29:1482-1488.
27. Micozzi A., Venditti M., Monaco M., et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000, 31:705-711.
28. Ferrà C., Marcos P., Misis M., et al. Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience. Int J Hematol 2007, 85:195-202.
29. Hampshire P.A., Welch C.A., McCrossan L.A., et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009, 13:R137.
30. Hilbert G., Gruson D., Vargas F., et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001, 344:481-487.